Investigation of Pain Coping Methods and Related Factors in Postmenopausal Women
NCT ID: NCT04543435
Last Updated: 2021-01-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
60 participants
OBSERVATIONAL
2020-09-17
2020-11-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Effect of Myofascial Induction and Therapeutic Pain Education in Chronic Low Back Pain
NCT03696979
Assessment of Musculoskeletal Pain and Psychosocial Status of Athletes
NCT03628547
Investigation of the Relationship of Pain Perception and Pain Belief With Age in People With Chronic Lack Pain
NCT05997368
Reliability and Validity of the Turkish Version of the Coping Strategies Questionnaire
NCT03890081
Comparison of Pain, Physical, and Psychosocial Parameters in Women With and Without Primary Dysmenorrhea
NCT07341685
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Oestrogen has a prominent role in the physiology of muscles, tendons, ligaments, and bones. The decline of this sex hormone during menopause transition could lead to MSP, particularly in the postmenopausal period. Indeed, an increasing rate of cMSP in postmenopausal women has been reported.
Coping strategies with pain are used to manage the pain and its impacts. Coping with pain requires the self-regulation of individuals using cognitive and behavioral reactions. Dealing with cMSP is a process that can need the making of changes in daily life and activities This study aimed to compare active and passive coping strategies being used and pain severity in postmenopausal women according to their age, marital status, educational status, and exercise habits. Also, subdomains of strategies and subdomains of pain and the relationship between pain and coping strategies in postmenopausal women with cMSP will be examined.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
CROSS_SECTIONAL
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* presenting at least 1 year of amenorrhea
* being between the ages of 50-69 years.
Exclusion Criteria
* have compression fractures, malignancies,
* have a chronic disease that will lead to secondary osteoporosis,
* have a drug use that will lead to secondary osteoporosis
50 Years
69 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
European University of Lefke
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Beliz B Kaygısız, PT, PhD
Role: PRINCIPAL_INVESTIGATOR
European University of Lefke
Nuray Elibol
Role: STUDY_DIRECTOR
Ege University
Sevim Acaröz Candan
Role: STUDY_CHAIR
Ordu University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
European University of Lefke
Mersin, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ÜEK/47/01/12/1920/05
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.